Projected differences in wait times for diagnosis of Alzheimer’s disease for individuals dually eligible for Medicare and Medicaid in the U.S due to higher disease burden and obstacles to access
Soeren Mattke, Samantha Chu, Hankyung Jun, Mark Hanson · 2025
Read Projected differences in wait times for diagnosis of Alzheimer’s disease for individuals dually eligible for Medicare and Medicaid in the U.S due to higher disease burden and obstacles to access by Soeren Mattke, Samantha Chu, Hankyung Jun, Mark Hanson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714582.txt.
Description
Long waits for an Alzheimer's diagnosis may hit poor older adults hardest, Soeren Mattke and co-authors model in a 2025 study. New drugs that slow the disease make early diagnosis more valuable, but clinics may not cope with demand. Adults covered by both Medicare and Medicaid face a triple load: more disease, fewer clinics that take their coverage, and state pay caps.
A Markov model forecasts waits for both coverage groups in every state through 2050. Inputs count disease burden and access blocks state by state. The results project where gaps will widen most. Planners can use the map to target clinic growth and pay fixes before backlogs lock in unfair delays.
Catalog record
| CREATOR | Soeren Mattke, Samantha Chu, Hankyung Jun, Mark Hanson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |